Navigation Links
MedCath Corporation to Hold Conference Call on Second Quarter Results
Date:5/20/2009

CHARLOTTE, N.C., May 20 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) will host a conference call Friday, May 22, at 10 a.m. Eastern Time to discuss results from its second quarter ended March 31, 2009. The company will issue a press release announcing those results and file its Form 10-Q with the Securities and Exchange Commission prior to the earnings call.

          What:       Second Quarter Earnings Conference Call

          When:       10:00 a.m ET, Friday, May 22, 2009

          How:        Dial-in conference call
                     (877) 697-5351 (domestic callers), (706) 634-0602
                     (international callers)
                      Conference ID:  11062123

                      Live web cast at www.medcath.com

          Contacts:   O. Edwin French, President & CEO
                      Jeff Hinton, CFO

The conference call will be archived and accessible by dialing (800) 642-1687 (domestic callers) or (706) 645-9291 (international callers). The archived conference ID is 11062123. The call will be accessible until 11:59 p.m. ET on June 5, 2009. It also will be available on the company's web site (www.medcath.com) on or immediately following May 22 for 30 days.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 676 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital, which is anticipated to open in fall 2009, in Kingman, Ariz. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

Parts of this announcement contain forward-looking statements that involve risks and uncertainties, including the announcement of earnings for our fiscal quarter ended March 31, 2009, the filing of our Form 10-Q for the same period and compliance with the reporting and other requirements of our credit agreement. Although management believes that these forward-looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control including, but not limited to, enactment of changes in federal law that would limit physician hospital ownership. Actual results could differ materially from those projected in these forward-looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy.


'/>"/>
SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. David Covert to Join MedCath as Senior Vice President, Operations
2. MedCath Corporation Announces Delay in 2nd Quarter Earnings Announcement and Filing of Form 10-Q
3. MedCath Corporation to Present at the Raymond James & Associates 30th Annual Institutional Investors Conference
4. MedCath Corporation Reports First Quarter Earnings
5. MedCath Corporation to Hold Conference Call on First Quarter Results
6. MedCath Corporation Announces Completion of Sale of Equity Interest in Joint Venture
7. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
8. MedCath Corporation Reports Third Quarter Earnings
9. MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
10. MedCath Names Parker to New Finance Post
11. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... 24, 2017 , ... Accordant Technology, a trusted IT solutions ... an analytics-first approach, layered with machine learning, that provides real-time visibility into the ... cloud to the edge. Through the new partnership, customers get the real-time situational ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... for-profit and nonprofit hospitals and health systems in the nation and help their ... institutions, led professional organizations and been instrumental in developing successful hospital and health ...
(Date:5/23/2017)... City (PRWEB) , ... May 23, 2017 , ... ... Population Health and Clinical Integration company, announced today that its iClinic V12.2 ... Home (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May 23, 2017—Total ... according to a Workers Compensation Research Institute (WCRI) study, a contrast from the ... System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical payments for ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: ... serve earlier this month as a Guest Speaker and Contributor to a weeklong series ... and Common Purpose. , Walter Schindler and SAIL Capital ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
Breaking Medicine Technology: